chiglitazar: Clinical Trials

2 trials of chiglitazar, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 31Completed 1

Follow chiglitazar: new trials by email Literature Review of chiglitazar trials Research Report on chiglitazar

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus
Chiglitazar Placebo, Chiglitazar, vitamin E - MASH - Metabolic Dysfunction-Associated Steatohepatitis, T2DM (Type 2 Diabetes Mellitus)
Phase 2RecruitingShanghai Jiao Tong University School of Medicine3002026-01-012026-06-03
Chiglitazar/Metformin in Non-obese Women With PCOS
Chiglitazar, Metformin - Polycystic Ovary Syndrome, Chiglitazar
Phase 2 / Phase 3CompletedShengjing Hospital552023-11-152025-01-01

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Polycystic Ovary Syndrome (1)

Sponsors

Shanghai Jiao Tong University School of Medicine (1)  ·  Shengjing Hospital (1)

Countries

China (2)

Top investigators

Hai Li, professor (1)

Results publications

PMID 41331576, PMID 42150836